BMS-833923-XL-139-DataSheet-生命科學(xué)試劑-MedChemExpress

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBMS-833923Cat. No.: HY-13809CAS No.: 1059734-66-5Synonyms: XL-139分式: CHNO分量: 473.57作靶點: Smo作通路: Stem Cell/Wnt儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 50 mg/mL (105.58 mM; Need ultras

2、onic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.1116 mL 10.5581 mL 21.1162 mL5 mM 0.4223 mL 2.1116 mL 4.2232 mL10 mM 0.2112 mL 1.0558 mL 2.1116 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度，選擇合適的溶劑配制儲備液，并請注意儲備液的保存式和期限。體內(nèi)實驗 請根據(jù)您的實驗動物和給藥式選擇適當(dāng)?shù)娜芙獍福渲魄罢埾扰渲瞥吻宓膬湟?，再依次添加助溶?為保證實驗結(jié)果的可靠性，體內(nèi)實驗的作液，建議您現(xiàn)現(xiàn)配，當(dāng)天使；澄清的儲備液可以根據(jù)儲存條件，適當(dāng)保存

3、；以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占)：1. 請依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.28 mM); Clear solutionBIOLOGICAL ACTIVITY1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemE物活性 BMS-833923 (XL-139)服物相容性的Smoothened抑制劑，有抗腫瘤活性，能劑量依賴性抑制BODIPYcyclopamine與SMO的結(jié)合，IC50為21 nM。REFEREN

4、CES1. Steven B, et al. Abstract B192: Preclinical characterization of BMS-833923 (XL139), a hedgehog (HH) pathway inhibitor in early clinicaldevelopment. Molecular Cancer Therapeutics: December 2009; Volume 8, Issue 12, Supplement 1.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.Tel: 400-820-3792;Fax: 021